Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

NCT05797168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

506

Enrollment

INDUSTRY

Sponsor class

Conditions

Ovarian Cancer
Lung Adenocarcinoma
Endometrial Cancer

Interventions

DRUG: AZD5335
DRUG: Saruparib (AZD5305)
DRUG: Bevacizumab
DRUG: Carboplatin
DRUG: AZD9574

Sponsor

AstraZeneca